• Consensus Rating: Buy
  • Consensus Price Target: $495.37
  • Forecasted Upside: 3.43 %
  • Number of Analysts: 19
  • Breakdown:
  • 0 Sell Ratings
  • 6 Hold Ratings
  • 13 Buy Ratings
  • 0 Strong Buy Ratings
▲ +10.89 (2.33%)

This chart shows the closing price for HUM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Humana Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HUM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HUM

Analyst Price Target is $495.37
▲ +3.43% Upside Potential
This price target is based on 19 analysts offering 12 month price targets for Humana in the last 3 months. The average price target is $495.37, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 3.43% upside from the last price of $478.96.

This chart shows the closing price for HUM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 19 investment analysts is to buy stock in Humana. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 15 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 10 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 11 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 6 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 13 buy ratings
  • 6 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 13 buy ratings
  • 6 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/16/2022Loop CapitalInitiated CoverageBuy$510.00Medium
5/26/2022Sanford C. BernsteinInitiated CoverageMarket Perform$480.00 ➝ $506.00Medium
5/25/2022Wells Fargo & CompanyBoost Price TargetOverweight$512.00 ➝ $514.00Low
4/28/2022Wells Fargo & CompanyBoost Price Target$491.00 ➝ $512.00High
4/13/2022UBS GroupUpgradeNeutral ➝ Buy$486.00 ➝ $520.00Medium
4/7/2022Truist FinancialBoost Price Target$460.00 ➝ $490.00High
3/9/2022Morgan StanleyBoost Price TargetEqual Weight$410.00 ➝ $436.00Low
2/3/2022Deutsche Bank AktiengesellschaftBoost Price Target$418.00 ➝ $435.00Medium
2/3/2022SVB LeerinkLower Price TargetOutperform$528.00 ➝ $525.00Medium
1/11/2022Sanford C. BernsteinLower Price Target$470.00 ➝ $431.00Low
1/7/2022MizuhoReiterated RatingBuy$500.00High
1/7/2022UBS GroupReiterated RatingHold$486.00High
1/7/2022BMO Capital MarketsLower Price Target$490.00 ➝ $415.00Low
1/7/2022Wells Fargo & CompanyLower Price Target$529.00 ➝ $452.00Low
1/7/2022Deutsche Bank AktiengesellschaftLower Price TargetHold ➝ Hold$476.00 ➝ $418.00Low
1/7/2022Morgan StanleyLower Price TargetEqual Weight$530.00 ➝ $410.00High
1/7/2022BarclaysLower Price TargetOverweight$540.00 ➝ $490.00High
1/6/2022Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$492.00 ➝ $529.00High
1/5/2022Truist FinancialBoost Price TargetHold ➝ Hold$500.00 ➝ $520.00Low
12/16/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight$559.00 ➝ $530.00Low
12/14/2021The Goldman Sachs GroupInitiated CoverageNeutral$472.00High
11/10/2021MizuhoBoost Price TargetBuy$480.00 ➝ $500.00Low
11/9/2021Deutsche Bank AktiengesellschaftBoost Price TargetHold$427.00 ➝ $456.00Low
11/9/2021CitigroupBoost Price TargetBuy$510.00 ➝ $528.00Low
11/4/2021Bank of AmericaBoost Price TargetBuy$505.00 ➝ $530.00Low
11/4/2021Morgan StanleyBoost Price TargetOverweight$513.00 ➝ $559.00Low
11/4/2021OppenheimerBoost Price TargetOutperform$480.00 ➝ $510.00Medium
11/4/2021Credit Suisse GroupBoost Price TargetOutperform$500.00 ➝ $513.00Medium
11/4/2021SVB LeerinkBoost Price TargetOutperform$494.00 ➝ $528.00Medium
11/4/2021Royal Bank of CanadaBoost Price TargetOutperform$479.00 ➝ $525.00Medium
11/4/2021BarclaysBoost Price TargetOverweight$500.00 ➝ $540.00Medium
9/27/2021SVB LeerinkInitiated CoverageOutperform$494.00Low
9/9/2021CowenInitiated CoverageOutperform$479.00High
9/9/2021BarclaysInitiated CoverageOverweight$500.00Low
8/31/2021Morgan StanleyBoost Price TargetOverweight$500.00 ➝ $513.00Low
7/9/2021Seaport Res PtnReiterated RatingNeutralLow
7/9/2021JPMorgan Chase & Co.Boost Price TargetOverweight$440.00 ➝ $514.00Low
5/24/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$472.00N/A
5/18/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$472.00Medium
4/29/2021CitigroupBoost Price Target$496.00 ➝ $510.00Low
4/29/2021OppenheimerBoost Price TargetOutperform$460.00 ➝ $480.00Low
4/29/2021MizuhoBoost Price TargetBuy$462.00 ➝ $480.00Medium
1/6/2021ArgusBoost Price TargetBuy$430.00 ➝ $450.00N/A
1/4/2021Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$429.00 ➝ $479.00N/A
11/30/2020SVB LeerinkLower Price TargetSell ➝ Outperform$505.00 ➝ $500.00High
11/4/2020Smith Barney CitigroupBoost Price Target$469.00 ➝ $496.00Low
11/4/2020Credit Suisse GroupBoost Price TargetOutperform$423.00 ➝ $465.00Low
11/4/2020OppenheimerBoost Price TargetOutperform$440.00 ➝ $460.00Low
11/4/2020StephensBoost Price TargetOverweight$450.00 ➝ $490.00Low
10/13/2020Truist FinancialBoost Price Target$455.00 ➝ $475.00Low
10/1/2020Sanford C. BernsteinInitiated CoverageMarket Perform$459.00Medium
10/1/2020Piper SandlerBoost Price TargetOverweight$473.00 ➝ $495.00Low
9/10/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$397.00 ➝ $431.00High
8/18/2020JPMorgan Chase & Co.Boost Price TargetOverweight$394.00 ➝ $452.00Low
8/17/2020Royal Bank of CanadaBoost Price TargetSector Perform$388.00 ➝ $420.00Low
8/10/2020StephensBoost Price TargetOverweight$433.00 ➝ $450.00Low
8/7/2020MizuhoBoost Price TargetBuy$420.00 ➝ $462.00High
8/6/2020Credit Suisse GroupReiterated RatingBuyLow
8/6/2020Piper SandlerBoost Price TargetOverweight$442.00 ➝ $473.00Medium
8/6/2020OppenheimerBoost Price TargetOutperform$425.00 ➝ $440.00Low
8/6/2020SVB LeerinkBoost Price TargetOutperform$465.00 ➝ $496.00Medium
7/1/2020SVB LeerinkInitiated CoverageOutperform$465.00Low
6/18/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$421.00 ➝ $397.00Low
6/17/2020Cantor FitzgeraldBoost Price Target$405.00 ➝ $410.00Medium
6/16/2020CowenReiterated RatingOutperform ➝ Market Perform$410.00Medium
6/5/2020The Goldman Sachs GroupInitiated CoverageBuy$510.00Medium
5/21/2020SunTrust BanksBoost Price TargetHold$400.00 ➝ $440.00Low
5/4/2020MizuhoBoost Price TargetBuy$405.00 ➝ $420.00Low
4/30/2020CSFBBoost Price TargetOutperform$400.00 ➝ $423.00Medium
4/30/2020Credit Suisse GroupBoost Price TargetOutperform$400.00 ➝ $423.00High
4/30/2020CitigroupBoost Price TargetBuy$424.00 ➝ $435.00Medium
4/30/2020Morgan StanleyBoost Price TargetOverweight$375.00 ➝ $500.00Medium
4/30/2020OppenheimerBoost Price TargetOutperform$400.00 ➝ $425.00Medium
4/13/2020Morgan StanleyBoost Price TargetOverweight$343.00 ➝ $375.00Medium
3/29/2020BarclaysReiterated RatingBuyHigh
3/27/2020Morgan StanleyLower Price TargetOverweight$460.00 ➝ $343.00Medium
2/19/2020Royal Bank of CanadaReiterated RatingHold$370.00Low
2/18/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$363.00 ➝ $433.00Medium
2/14/2020MizuhoReiterated RatingBuy$405.00N/A
2/6/2020Morgan StanleyBoost Price TargetOverweight$457.00 ➝ $460.00Low
2/6/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$319.00 ➝ $363.00Medium
2/6/2020MizuhoBoost Price TargetBuy$400.00 ➝ $405.00Medium
2/5/2020Cantor FitzgeraldBoost Price TargetOverweight$345.00 ➝ $400.00Low
1/27/2020The Goldman Sachs GroupReiterated RatingBuy$425.00Medium
1/23/2020UBS GroupBoost Price TargetNeutral$321.00 ➝ $406.00Low
1/8/2020Credit Suisse GroupBoost Price TargetOutperform$378.00 ➝ $400.00High
1/3/2020JPMorgan Chase & Co.Boost Price TargetOverweight$437.00 ➝ $448.00Medium
1/3/2020The Goldman Sachs GroupReiterated RatingBuy ➝ Buy$425.00 ➝ $425.00Medium
12/20/2019JPMorgan Chase & Co.Boost Price TargetOverweight$322.00 ➝ $437.00Low
12/17/2019SunTrust BanksReiterated RatingHold$370.00Low
12/11/2019Wells Fargo & CompanyReiterated RatingOverweight$338.00 ➝ $400.00Low
12/6/2019BarclaysBoost Price TargetOverweight$327.00 ➝ $358.00Low
11/20/2019ArgusBoost Price TargetBuy$370.00Low
11/18/2019Morgan StanleyReiterated RatingBuy$337.00 ➝ $360.00Low
11/15/2019SunTrust BanksBoost Price TargetPositive ➝ Hold$350.00High
11/7/2019SunTrust BanksBoost Price TargetHold$335.00High
10/17/2019MizuhoInitiated CoverageBuy$316.00High
9/30/2019BMO Capital MarketsDowngradeOutperform ➝ Market Perform$345.00 ➝ $290.00Low
9/26/2019Morgan StanleyLower Price TargetOverweight$342.00 ➝ $337.00High
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageHold$300.00High
8/23/2019Morgan StanleyBoost Price TargetOverweight$315.00 ➝ $342.00Medium
8/12/2019Cantor FitzgeraldUpgradeNeutral ➝ Overweight$300.00 ➝ $345.00Medium
8/1/2019JPMorgan Chase & Co.Boost Price TargetOverweight$288.00 ➝ $322.00Low
8/1/2019Piper Jaffray CompaniesBoost Price TargetOverweight$315.00 ➝ $341.00Low
8/1/2019UBS GroupBoost Price TargetNeutral$266.00 ➝ $317.00Low
8/1/2019SunTrust BanksBoost Price TargetHold$340.00Low
7/12/2019Morgan StanleyLower Price TargetOverweight$331.00 ➝ $315.00High
5/2/2019SunTrust BanksLower Price Target$300.00Low
5/2/2019OppenheimerLower Price TargetOutperform$373.00 ➝ $350.00Low
5/2/2019Morgan StanleySet Price TargetBuy$331.00Low
5/2/2019Credit Suisse GroupLower Price TargetOutperform$352.00 ➝ $315.00Low
5/2/2019CitigroupLower Price TargetBuy ➝ Buy$362.00 ➝ $302.00Low
4/23/2019UBS GroupInitiated CoverageNeutral ➝ Neutral$266.00Medium
4/17/2019BarclaysLower Price TargetOverweight ➝ Overweight$351.00 ➝ $327.00Low
2/7/2019CitigroupLower Price TargetBuy ➝ Buy$397.00 ➝ $362.00Low
2/7/2019Credit Suisse GroupLower Price TargetOutperform$390.00 ➝ $352.00Low
1/14/2019StephensInitiated CoverageOverweight$336.00Low
1/11/2019CowenUpgradeMarket Perform ➝ Outperform$275.02High
1/6/2019BarclaysReiterated RatingBuy$351.00Low
1/2/2019Cantor FitzgeraldReiterated RatingHold$325.00High
12/20/2018JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$283.00Medium
11/8/2018Morgan StanleyBoost Price TargetOverweight ➝ Buy$400.00 ➝ $418.00Low
11/8/2018BMO Capital MarketsSet Price TargetBuy$390.00Low
11/8/2018Royal Bank of CanadaBoost Price TargetSector Perform ➝ Sector Perform$318.00 ➝ $349.00Low
11/8/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$370.00 ➝ $390.00Low
11/8/2018Bank of AmericaBoost Price TargetBuy$400.00 ➝ $415.00Medium
11/8/2018Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$388.00 ➝ $410.00High
9/19/2018SunTrust BanksBoost Price TargetHold$380.00Low
9/17/2018CowenInitiated CoverageMarket Perform$372.00Low
9/13/2018BarclaysInitiated CoverageOverweight ➝ Overweight$370.00Medium
9/4/2018Credit Suisse GroupBoost Price TargetOutperform$350.00 ➝ $370.00Low
9/4/2018ArgusBoost Price TargetBuy$375.00Low
8/24/2018Piper Jaffray CompaniesBoost Price TargetOverweight$355.00 ➝ $380.00Low
8/2/2018SunTrust BanksReiterated RatingHold$350.00Low
8/2/2018Piper Jaffray CompaniesReiterated RatingBuy$355.00Low
8/2/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$338.00 ➝ $375.00Low
8/2/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$362.00 ➝ $365.00Low
8/2/2018Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$356.00 ➝ $372.00Low
8/2/2018Royal Bank of CanadaReiterated RatingHold$318.00Low
7/12/2018Morgan StanleyInitiated CoverageOverweight$362.00Low
7/6/2018Piper Jaffray CompaniesBoost Price TargetOverweight$326.00 ➝ $350.00Medium
6/25/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$328.00 ➝ $355.00Low
6/1/2018CitigroupReiterated RatingBuy ➝ Buy$280.00 ➝ $340.00Low
5/3/2018OppenheimerBoost Price TargetOutperform$305.00 ➝ $311.00Low
4/23/2018Cantor FitzgeraldReiterated RatingHold$250.00High
4/16/2018ArgusBoost Price TargetBuy ➝ Buy$270.00 ➝ $330.00Low
4/4/2018Piper Jaffray CompaniesReiterated RatingBuy$313.00Low
2/12/2018JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$253.00 ➝ $271.00Low
2/9/2018Deutsche Bank AktiengesellschaftBoost Price TargetHold ➝ Hold$259.00 ➝ $270.00Low
2/8/2018OppenheimerBoost Price TargetOutperform$275.00 ➝ $305.00Medium
2/8/2018SVB LeerinkBoost Price TargetOutperform ➝ Outperform$280.00 ➝ $300.00High
2/8/2018Credit Suisse GroupUpgradeNeutral ➝ Outperform$264.90 ➝ $246.00Medium
2/7/2018Cantor FitzgeraldReiterated RatingHold$250.00Medium
1/12/2018Jefferies Financial GroupUpgradeHold ➝ Buy$221.00Medium
1/3/2018The Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$305.00Low
12/13/2017CowenReiterated RatingBuy$285.00Low
12/5/2017Cantor FitzgeraldReiterated RatingHold$230.00Low
11/10/2017Credit Suisse GroupLower Price TargetNeutral$256.00 ➝ $246.00N/A
11/10/2017BMO Capital MarketsBoost Price TargetOutperform$290.00 ➝ $300.00N/A
11/9/2017Morgan StanleyLower Price TargetOverweight$276.00 ➝ $270.00N/A
11/9/2017Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$245.00 ➝ $242.00N/A
11/2/2017Credit Suisse GroupInitiated CoverageNeutral$256.00N/A
10/16/2017BMO Capital MarketsInitiated CoverageOutperform$300.00N/A
10/13/2017Jefferies Financial GroupReiterated RatingHold$257.00N/A
10/10/2017Royal Bank of CanadaReiterated RatingHold$245.00N/A
10/9/2017JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$253.00N/A
9/20/2017CowenReiterated RatingOutperform$230.00 ➝ $275.00Medium
8/17/2017Morgan StanleyBoost Price TargetOverweight$269.00 ➝ $276.00Low
8/9/2017UBS GroupReiterated RatingNeutral$237.00 ➝ $250.00Low
8/7/2017Deutsche Bank AktiengesellschaftBoost Price TargetHold$234.00 ➝ $243.00Low
8/4/2017Jefferies Financial GroupReiterated RatingHold$257.00Low
8/3/2017Cantor FitzgeraldReiterated RatingNeutral$200.00 ➝ $223.00Low
8/3/2017OppenheimerBoost Price TargetOutperform$236.00 ➝ $255.00Medium
8/3/2017Credit Suisse GroupReiterated RatingOutperform$250.00 ➝ $260.00High
8/3/2017Piper Jaffray CompaniesBoost Price TargetOverweight$280.00High
7/14/2017Piper Jaffray CompaniesReiterated RatingBuy$246.00Low
7/14/2017CowenReiterated RatingBuy$230.00Low
7/14/2017Bank of AmericaBoost Price TargetBuy$270.00 ➝ $275.00Low
7/13/2017Credit Suisse GroupReiterated RatingOutperform$245.00 ➝ $250.00Low
(Data available from 7/5/2017 forward)

News Sentiment Rating

0.50 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 10 very positive mentions
  • 29 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 7 very positive mentions
  • 19 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
  • 16 very positive mentions
  • 32 positive mentions
  • 9 negative mentions
  • 1 very negative mentions
  • 9 very positive mentions
  • 37 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
  • 9 very positive mentions
  • 18 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
  • 18 very positive mentions
  • 47 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
  • 7 very positive mentions
  • 26 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
  • 11 very positive mentions
  • 29 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Current Sentiment

  • 11 very positive mentions
  • 29 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Humana logo
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Read More

Today's Range

Now: $478.96
Low: $463.24
High: $479.52

50 Day Range

MA: $444.16
Low: $420.04
High: $478.96

52 Week Range

Now: $478.96
Low: $351.20
High: $479.73


30,278 shs

Average Volume

1,126,769 shs

Market Capitalization

$60.59 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Humana?

The following sell-side analysts have issued reports on Humana in the last twelve months: Bank of America Co., Barclays PLC, BMO Capital Markets, Citigroup Inc., Cowen Inc, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Loop Capital, Mizuho, Morgan Stanley, Oppenheimer Holdings Inc., Royal Bank of Canada, Sanford C. Bernstein, Seaport Global Securities, Seaport Res Ptn, StockNews.com, SVB Leerink LLC, The Goldman Sachs Group, Inc., Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for HUM.

What is the current price target for Humana?

0 Wall Street analysts have set twelve-month price targets for Humana in the last year. Their average twelve-month price target is $495.37, suggesting a possible upside of 3.4%.
View the latest price targets for HUM.

What is the current consensus analyst rating for Humana?

Humana currently has 6 hold ratings and 13 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe HUM will outperform the market and that investors should add to their positions of Humana.
View the latest ratings for HUM.

What other companies compete with Humana?

How do I contact Humana's investor relations team?

Humana's physical mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider's listed phone number is (502) 580-1000 and its investor relations email address is [email protected] The official website for Humana is www.humana.com. Learn More about contacing Humana investor relations.